MannKind Corporation (NASDAQ:MNKD) reported its second-quarter earnings yesterday, and the numbers didn't paint a pretty picture, to put it lightly. In fact, the struggling inhaled insulin company is facing a serious cash crisis that it might not be able to solve without drastic measures. Unfortunately for shareholders, one of those measures could be declaring bankruptcy.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,